Khan W, Khan N, Tembhre M, Malik Z, Ansari M, Mishra A
Mol Divers. 2025; .
PMID: 40085404
DOI: 10.1007/s11030-025-11163-0.
Qian Q, Lyu H, Wang W, Wang Q, Li D, Liu X
Funct Integr Genomics. 2025; 25(1):64.
PMID: 40085348
DOI: 10.1007/s10142-025-01573-6.
Dong F, Annalora A, Murray I, Chakraborty D, Coslo D, Marcus C
Nutrients. 2025; 17(5).
PMID: 40077746
PMC: 11901531.
DOI: 10.3390/nu17050876.
Falsetti I, Palmini G, Zonefrati R, Vasa K, Donati S, Aurilia C
Int J Mol Sci. 2025; 26(5).
PMID: 40076925
PMC: 11900421.
DOI: 10.3390/ijms26052305.
Otani K, Komatsu R, Noguchi T, Suzuki W, Hirata Y, Matsuzawa A
Int J Mol Sci. 2025; 26(5).
PMID: 40076859
PMC: 11899812.
DOI: 10.3390/ijms26052237.
Design and Synthesis of New 5-Methylisatin Derivatives as Potential CDK2 Inhibitors.
Czelen P, Skotnicka A, Szefler B, Kabatc-Borcz J, Sutkowy P
Int J Mol Sci. 2025; 26(5).
PMID: 40076766
PMC: 11900410.
DOI: 10.3390/ijms26052144.
Synthesis, Characterization, and Docking Studies of Some New Chalcone Derivatives to Alleviate Skin Damage Due to UV Light.
Mishra A, Thajudeen K, Shekhar C, Singh M, Singh H, Kumar A
Molecules. 2025; 30(5).
PMID: 40076281
PMC: 11901719.
DOI: 10.3390/molecules30051057.
Identification of (L.) Merr as a Novel Potential Therapeutic Agent Against COVID-19 and Pharyngitis.
Chen Q, He H, Zhu Y, Li X, Fang J, Li Z
Molecules. 2025; 30(5).
PMID: 40076279
PMC: 11901475.
DOI: 10.3390/molecules30051055.
Ligand-Induced Biased Activation of GPCRs: Recent Advances and New Directions from In Silico Approaches.
Hashem S, Dougha A, Tuffery P
Molecules. 2025; 30(5).
PMID: 40076272
PMC: 11901715.
DOI: 10.3390/molecules30051047.
Chemical Composition and Larvicidal Activity Against of the Leaf Essential Oils from .
Lopes P, Pereira N, da Rocha M, Marinho M, Guedes J, Rodrigues T
Molecules. 2025; 30(5).
PMID: 40076259
PMC: 11901792.
DOI: 10.3390/molecules30051034.
Morpholine-Substituted Tetrahydroquinoline Derivatives as Potential mTOR Inhibitors: Synthesis, Computational Insights, and Cellular Analysis.
Dey R, Shaw S, Yadav R, Patel B, Bhatt H, Natesan G
Cancers (Basel). 2025; 17(5).
PMID: 40075606
PMC: 11898650.
DOI: 10.3390/cancers17050759.
Hypoxia tolerance determine differential gelsenicine-induced neurotoxicity between pig and mouse.
Huang C, Zuo M, Qi X, Gong M, Xu W, Meng S
BMC Med. 2025; 23(1):156.
PMID: 40075370
PMC: 11905507.
DOI: 10.1186/s12916-025-03984-5.
A structure-based framework for selective inhibitor design and optimization.
Zou Y, Guo T, Fu Z, Guo Z, Bo W, Yan D
Commun Biol. 2025; 8(1):422.
PMID: 40075154
PMC: 11903766.
DOI: 10.1038/s42003-025-07840-3.
Unraveling the mechanisms of benzimidazole resistance in hookworms: A molecular docking and dynamics study.
Tenorio J, Heikal M, Kafle A, Macalalad M, Orosco F, Saichua P
J Genet Eng Biotechnol. 2025; 23(1):100472.
PMID: 40074446
PMC: 11879688.
DOI: 10.1016/j.jgeb.2025.100472.
Telomeric RNA quadruplexes as targets for cancer prevention: The therapeutic potential of agonodepsides.
Choudhir G, Kumar S, Shahid M, Shamsi A, Islam A
J Genet Eng Biotechnol. 2025; 23(1):100454.
PMID: 40074428
PMC: 11750472.
DOI: 10.1016/j.jgeb.2024.100454.
Isolation, total synthesis and structure determination of antifungal macrocyclic depsipeptide, tetraselide.
Nakahara H, Sennari G, Azami H, Tsutsumi H, Watanabe Y, Noguchi Y
Chem Sci. 2025; .
PMID: 40070467
PMC: 11892018.
DOI: 10.1039/d5sc00566c.
Comparison of PDE-5 inhibitors used in erectile dysfunction with some candidate molecules: A study involving molecular docking, ADMET, DFT, biological target, and activity.
Sagir S, Unsal V, Oner E, Yildiz R, Mert B
BMC Urol. 2025; 25(1):47.
PMID: 40069715
PMC: 11895370.
DOI: 10.1186/s12894-025-01727-5.
An efficient deep learning-based strategy to screen inhibitors for GluN1/GluN3A receptor.
Wang Z, Zeng Y, Sun J, Chen X, Wu H, Li Y
Acta Pharmacol Sin. 2025; .
PMID: 40069493
DOI: 10.1038/s41401-025-01513-x.
Revisiting the druggable genome using predicted structures and data mining.
Godinez-Macias K, Chen D, Wallis J, Siegel M, Adam A, Bopp S
NPJ Drug Discov. 2025; 2(1):3.
PMID: 40066064
PMC: 11892419.
DOI: 10.1038/s44386-025-00006-5.
(Z)-N-(3-([1,1'-biphenyl]-2-yl)-4-heptyl-4-hydroxythiazolidin-2-ylidene)-4-bromobenzamide as carbonic anhydrase inhibitor: exploration of its in vitro and in silico studies.
Ahmed A, Ilyas S, Ali Channar P, Ejaz S, Saeed A, Ghumro S
BMC Chem. 2025; 19(1):65.
PMID: 40065376
PMC: 11892125.
DOI: 10.1186/s13065-025-01423-3.